Navigation Links
invivodata Recognized as One of Pittsburgh's Fastest Growing Private Companies
Date:9/1/2009

PITTSBURGH, Sept. 1 /PRNewswire/ -- invivodata inc., the industry leader in electronic patient reported outcomes (ePRO) solutions and services for global clinical research, today announced that the company has been recognized in the "2009 Pittsburgh 100" annual ranking of the fastest-growing, privately-held companies in Western Pennsylvania by the Pittsburgh Business Times.

"We see the Pittsburgh 100 as one of the most important lists we publish," said Alan Robertson, publisher of the Pittsburgh Business Times. "The companies on this list represent many industries and many geographic locations around the region. The Pittsburgh 100 companies also represent all different sizes of companies, from small firms to multi-billion dollar operations. The Pittsburgh 100 is proof that the region remains a vibrant, growth-oriented business environment."

invivodata was named to the annual Pittsburgh 100 based on its revenue growth rate from 2006 through 2008. Honored at an awards program at the Duquesne Club in downtown Pittsburgh on August 27, invivodata was ranked the 16th fastest-growing technology company and #87 overall on the list of 100, based on revenue growth.

"We are a proud member of the Pittsburgh business community and are very pleased to once again be included on this list," said Doug Engfer, invivodata president and CEO. "We believe our steady growth stems from our commitment to delivering value with our practical and reliable solutions and services that help pharmaceutical companies collect better data and run more efficient clinical trials."

In the past year, invivodata has led the industry in developing innovative patient and site based ePRO solutions to meet the evolving needs of global clinical trial sponsors. Strong growth in its scientific and regulatory consulting division, PRO Consulting(TM), coupled with expanded partnerships with Contract Research Organizations and integrations with market-leading eClinical systems has enabled the organization to continue delivering consistent results to new and existing customers.

For additional information on invivodata's solutions and services, visit www.invivodata.com.

About invivodata inc.

invivodata combines behavioral science, information technology, and clinical research expertise to capture high quality clinical trial data directly from patients. invivodata's electronic Patient Reported Outcomes (ePRO) solutions, which are based on over 20 years of research, deliver reliable patient self-reported data by driving patient compliance with the protocol and eliminating recall biases that plague paper-based self-report data. invivodata's solutions include comprehensive trial-support services that facilitate the collection of ePRO data, web-based access to study data and operational reports that give researchers and sponsors visibility into study progress, and scientific and regulatory consulting on the use of PRO data in a regulated environment. invivodata's solution has been used in more than 275 clinical programs and is the industry-leading ePRO system in delivering primary efficacy data for FDA drug approvals. invivodata inc. is a privately held company with global headquarters in Pittsburgh, Pa., USA; its European headquarters are in London, England; and its technology development center is in Scotts Valley, Calif., USA. For more information visit www.invivodata.com.

    For more information, contact:

    invivodata inc.
    Christine Tobin
    Corporate Communications Specialist
    (412) 390-3000, ext. 3502
    ctobin@invivodata.com


'/>"/>
SOURCE invivodata inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. invivodata Captures Symptom Relief Data in Endometriosis Trial
2. invivodata Certified to Deliver EXACT in COPD Trials
3. FreshFx Recognized for use in the Scalder as a Solution to the Yield/Pathogen Reduction Dilemma
4. Corgenix AspirinWorks(R) Test Recognized in POLYCAP Study at ACC.09
5. Genetic Engineering & Biotechnology News Reports on the Growing Role of Ion-Channel Studies in Global Biotech R&D
6. Accent on Aesthetics Plastic Surgery Medical Center Selects Artefill to Meet Growing Patient Demand for a Longer Lasting Dermal Filler
7. Paratek Pharmaceuticals Announces the Close of $40 Million Private Placement to Finance Programs to Combat MRSA Infections
8. NeuroVasx, Inc. Announces $8.5 Million Private Placement and Completion of cPAX Aneurysm Treatment Study
9. Lixte Biotechnology Holdings, Inc. Announces Completion of Private Placement
10. Radius Raises Additional $15 Million, Increasing Second Private Equity Financing Round to $82.5 Million
11. Ikaria(R) Named Private Company of the Year by New Jersey Technology Council
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/19/2017)... LONDON , January 19, 2017 Incretin ... Sympathomimetics and Others The global anti-obesity drugs ... the first half of the forecast period and CAGR of 38.7% ... expected to grow at a CAGR of 32.8% from 2016 to ... million in 2021, and $24,063 million in 2027. ...
(Date:1/19/2017)... Jan. 19, 2017  Sensus Healthcare, Inc. (NASDAQ: ... specializing in the treatment of non-melanoma skin cancers ... superficial radiation therapy, today announced that it will ... financial results on Thursday, February 2, 2017 after the ... a conference call with the investment community on Thursday, ...
(Date:1/19/2017)... LONDON , January 19, 2017 ... New Therapeutic Option to Address Motor Symptoms and ... ...      (Logo: http://photos.prnewswire.com/prnh/20151014/276718LOGO) ... Fabrizio Stocchi , European Neurological Review,2016;11(Suppl. 2): 2-15, ...
Breaking Medicine Technology:
(Date:1/19/2017)... ... 19, 2017 , ... In 2009, Carol Bryan endured immense ... severe facial disfiguration. After four frightening years of isolation and emotional and physical ... who removed the substances in a partial facial transplant through eight surgeries. ...
(Date:1/19/2017)... ... January 19, 2017 , ... ... panel system. , The Tranquility privacy panel system was designed to deliver ... Tranquility panels help reduce noise and provide the visual privacy required to maintain ...
(Date:1/19/2017)... ... January 19, 2017 , ... Sam & Associates Insurance ... commercial and residential clients in the California Bay Area, is launching a charity drive ... the region. , Heart disease is the primary killer of adult men and women ...
(Date:1/19/2017)... ... January 19, 2017 , ... For the ... Lawrenceville, New Jersey and the surrounding area, is inaugurating a charity event ... more commonly known as Lou Gehrig's disease or motor neurone disease, is a ...
(Date:1/19/2017)... ... January 19, 2017 , ... Creative messages ... Real Impact contest from Impact Teen Drivers and California Casualty. Entries from students ... , Educational grants totaling $15,000 will be awarded for the best peer-to-peer messages ...
Breaking Medicine News(10 mins):